JAK1 and acute lymphoblastic leukemia: However, another T-ALL cell line KOPTK1 also shows constitutive STAT5 phosphorylation that is resistant to ruxolitinib and IL-7 stimulation, suggesting this cell contains mutations that mediate STAT5 phosphorylation independent of JAK1 (Figure 2C).